Originele taal-2 | Engels |
---|---|
Pagina's (van-tot) | 1131-1135 |
Aantal pagina's | 5 |
Tijdschrift | Leukemia |
Volume | 26 |
Nummer van het tijdschrift | 5 |
DOI's | |
Status | Gepubliceerd - mei 2012 |
Extern gepubliceerd | Ja |
Toegang tot document
Citeer dit
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Leukemia, Vol. 26, Nr. 5, 05.2012, blz. 1131-1135.
Onderzoeksoutput: Bijdrage aan tijdschrift › Brief › peer review
TY - JOUR
T1 - AML1/ETO and POU4F1 synergy drives B-lymphoid gene expression typical of t(8;21) acute myeloid leukemia
AU - Dunne, J.
AU - Mannari, D.
AU - Farzaneh, T.
AU - Gessner, A.
AU - Van Delft, F. W.
AU - Heidenreich, O.
AU - Young, B. D.
AU - Gascoyne, D. M.
N1 - Funding Information: 1Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece; 2Laboratory of B cell Neoplasia and Unit of Lymphoid Malignancies, Division of Molecular Oncology, Department of Onco-Hematology and MAGIC (Microenvironment and Genes in Cancers of the blood) Interdivisional Research Program, Istituto Scientifico San Raffaele and Università Vita-Salute San Raffaele, Milano, Italy; 3School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece; 4Institute of Agrobiotechnology, Center for Research and Technology Hellas, Thessaloniki, Greece; 5Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Upssala, Sweden; 6IMGT, the international ImMunoGeneTics information system, Université Montpellier 2, Laboratoire d’ImmunoGénétique Moléculaire LIGM, UPR CNRS 1142, Montpellier, France; 7Department of Hematooncology, University Hospital Brno, and Central European Institute of Technology, Masaryk University, Brno, Czech Republic; 8Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK; 9Department of Haematology, Imperial College Academic Health Science Centre, Hammersmith Hospital, London, UK; 10CERMS, S. Giovanni Battista Hospital, Turin; Italy; 11Department of Hematology, Rigshospitalet, Copenhagen, Denmark; 12Pathology Unit and Unit of Lymphoid Malignancies, San Raffaele Scientific Institute, Milan, Italy; 13Centre for Immune Regulation, Institute of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway; 14Hematology Department, Nikea General Hospital, Athens, Greece and 15Laboratory of Hematology and Université Pierre et Marie Curie, Hôpital Pitié-Salpètrière, Paris, France E-mail: [email protected] {Deceased. 16Equal first authors. 17Equal senior authors.
PY - 2012/5
Y1 - 2012/5
UR - http://www.scopus.com/inward/record.url?scp=84860729659&partnerID=8YFLogxK
U2 - 10.1038/leu.2011.316
DO - 10.1038/leu.2011.316
M3 - Letter
C2 - 22064348
AN - SCOPUS:84860729659
SN - 0887-6924
VL - 26
SP - 1131
EP - 1135
JO - Leukemia
JF - Leukemia
IS - 5
ER -